Institutional investors purchased a net $32.1 thousand shares of OMER during the quarter ended December 2016, and now own 49.61% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CAPITAL IMPACT ADVISORS LLC Bought 94.6 Thousand shares of Omeros Corp
CANDRIAM LUXEMBOURG SA Bought 27.0 Thousand shares of Omeros Corp
CTC MYCFO LLC Bought 21.7 Thousand shares of Omeros Corp